Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher M. Sharland
Christopher M. Sharland
University of Bath
Biochemistry
Biology
Prostate cancer
Internal medicine
Endocrinology
5
Papers
90
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The design of novel 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors
2009
Molecular and Cellular Endocrinology
Nigel Vicker
Christopher M. Sharland
Wesley Heaton
Ana Maria Ramos Gonzalez
Helen Victoria Bailey
Andrew Smith
Jeremy S. Springall
Joanna M. Day
Helena J. Tutill
Michael J. Reed
Atul Purohit
Barry V. L. Potter
Show All
Source
Cite
Save
Citations (5)
Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17β-hydroxysteroid dehydrogenase Type 3
2009
Molecular and Cellular Endocrinology
Joanna M. Day
Helena J. Tutill
Paul Foster
Helen Victoria Bailey
Wesley Heaton
Christopher M. Sharland
Nigel Vicker
Barry V. L. Potter
Atul Purohit
Michael J. Reed
Show All
Source
Cite
Save
Citations (17)
The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors
2009
Molecular and Cellular Endocrinology
Nigel Vicker
Christopher M. Sharland
Wesley Heaton
Ana Maria Ramos Gonzalez
Helen Victoria Bailey
Andrew Smith
Jeremy S. Springall
Joanna M. Day
Helena J. Tutill
Michael J. Reed
Atul Purohit
Barry V. L. Potter
Show All
Source
Cite
Save
Citations (28)
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography
2008
Molecular Cancer Therapeutics
L. W. Lawrence Woo
Delphine S. Fischer
Christopher M. Sharland
Melanie Trusselle
Paul A. Foster
Surinder K. Chander
Anna Di Fiore
Claudiu T. Supuran
Giuseppina De Simone
Atul Purohit
Michael J. Reed
Barry V. L. Potter
Show All
Source
Cite
Save
Citations (35)
1